Paper Details

  1. Home
  2. Paper Details

Safety of long-term use of four common conventional disease modifying anti-rheumatic drugs in rheumatoid arthritis.

Author: GoyalMohit, KediaArun Kumar, MohansundaramKavitha, RavindranVinod

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

Conventional disease-modifying antirheumatic drugs (DMARDs) like methotrexate, leflunomide, hydroxychloroquine, and sulfasalazine are widely used for treating rheumatoid arthritis. This narrative review critically appraises the available literature on the long-term safety of these DMARDs, highlighting the importance of weighing their benefits against potential risks.
Paper Details　
Original Abstract of the Article :
Conventional disease-modifying antirheumatic drugs (DMARDs) have been used in the management of rheumatoid arthritis for a long time. Whereas methotrexate (MTX) is the anchor drug, leflunomide, hydroxychloroquine and sulfasalazine are used along with MTX either in combination or sequentially. Togeth...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.4997/JRCPE.2021.306

データ提供：米国国立医学図書館（NLM）

Safety of Conventional Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis

Conventional disease-modifying antirheumatic drugs (DMARDs) are widely used in managing rheumatoid arthritis. While methotrexate (MTX) is the anchor drug, leflunomide, hydroxychloroquine, and sulfasalazine are also commonly used in combination or sequentially. This study delves into the safety of these four DMARDs in long-term use.

The Safety of Long-Term DMARD Use

This research delves into the safety of four commonly used DMARDs in the long term. The authors conducted a comprehensive review of existing literature to evaluate the safety of these drugs. They highlighted the need for further research to optimize the long-term use of these drugs in clinical practice.

Safety Considerations for Rheumatoid Arthritis Treatment

Understanding the long-term safety of DMARDs is crucial for patients with rheumatoid arthritis. Long-term use can have potential side effects, making it vital to weigh the benefits against the risks. Regular monitoring and open communication with your doctor are essential to manage these medications effectively.

Dr. Camel's Conclusion

It's important to remember that managing rheumatoid arthritis requires a collaborative effort between patients and their healthcare providers. This study sheds light on the potential long-term risks associated with DMARDs. It's important to weigh the benefits of these drugs against potential side effects. By working together, patients and doctors can make informed decisions to ensure the best possible outcomes.

Date :
  1. Date Completed 2021-10-21
  2. Date Revised 2021-10-21
Further Info :

Pubmed ID

34528610

DOI: Digital Object Identifier

10.4997/JRCPE.2021.306

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.